Compounds > amoxicillin-potassium-clavulanate-combination

amoxicillin-potassium-clavulanate-combination and Metabolic-Syndrome

amoxicillin-potassium-clavulanate-combination has been researched along with Metabolic-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for amoxicillin-potassium-clavulanate-combination and Metabolic-Syndrome

Article	Year
Leclercia adecarboxylata bacteraemia in an immunocompromised patient with metabolic syndrome. Le infezioni in medicina, 2014, Volume: 22, Issue:2 Leclercia adecarboxylata is being increasingly diagnosed as a causative agent of infection due to the availability of rapid molecular diagnostic techniques Few cases of bacteraemia in subjects with underlying medical conditions have been reported. We report a case of L. adecarboxylata bacteraemia in an immunocompromised patient with metabolic syndrome. Topics: Amoxicillin-Potassium Clavulanate Combination; Bacteremia; Body Mass Index; Debridement; Diabetes Mellitus, Type 2; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Hypertension; Immunocompromised Host; Leg; Metabolic Syndrome; Middle Aged; Risk Factors; Treatment Outcome	2014

Article

Year

Leclercia adecarboxylata bacteraemia in an immunocompromised patient with metabolic syndrome.

Le infezioni in medicina, 2014, Volume: 22, Issue:2

Leclercia adecarboxylata is being increasingly diagnosed as a causative agent of infection due to the availability of rapid molecular diagnostic techniques Few cases of bacteraemia in subjects with underlying medical conditions have been reported. We report a case of L. adecarboxylata bacteraemia in an immunocompromised patient with metabolic syndrome.

Topics: Amoxicillin-Potassium Clavulanate Combination; Bacteremia; Body Mass Index; Debridement; Diabetes Mellitus, Type 2; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Hypertension; Immunocompromised Host; Leg; Metabolic Syndrome; Middle Aged; Risk Factors; Treatment Outcome

2014